Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
187 studies found for:    Encephalitis
Show Display Options
Rank Status Study
21 Active, not recruiting Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab
Condition: Encephalitis
Intervention: Biological: Nivolumab
22 Unknown  Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis
Condition: Rasmussen Encephalitis
Interventions: Drug: Tacrolimus;   Drug: i.v. immunoglobulins
23 Completed
Has Results
Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children
Condition: Encephalitis, Japanese B
Intervention: Biological: JEVAC
24 Completed
Has Results
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
25 Completed
Has Results
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
26 Completed
Has Results
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: IC51;   Biological: JE-VAX
27 Completed Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
28 Unknown  Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis chimeric vaccine (JECV)
29 Completed
Has Results
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis purified inactivated vaccine
30 Completed Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
31 Completed
Has Results
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX
Condition: Japanese Encephalitis
Interventions: Biological: ChimeriVax™-JE;   Biological: JE-VAX®
32 Completed
Has Results
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: Japanese Encephalitis purified inactivated vaccine (IC51);   Biological: Placebo
33 Completed
Has Results
Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
34 Completed
Has Results
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
35 Completed
Has Results
Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis purified inactivated vaccine
36 Completed
Has Results
Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Intervention: Biological: Live attenuated SA 14-14-2 vaccine
37 Recruiting Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj
Condition: Japanese Encephalitis
Intervention: Biological: Inactivated Japanese encephalitis vaccine (Beijing-Handai strain, cell-cultured)
38 Recruiting Tick-borne Encephalitis and Positive Borrelial Antibodies
Condition: Tick-borne Encephalitis
Interventions: Drug: Doxycycline;   Drug: Symptomatic therapy;   Other: Questionnaire
39 Completed A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis
Conditions: Chronic Focal Encephalitis;   Rasmussen's Encephalitis
Intervention: Drug: Rituximab
40 Completed Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
Condition: Tick-Borne Encephalitis
Interventions: Biological: LGT(TP21)/DEN4;   Biological: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.